Information
-
Trademark
-
79326685
-
International Classifications
-
Filing Date
September 20, 2021
3 years ago
-
Transaction Date
November 08, 2024
2 months ago
-
Status Date
January 03, 2023
2 years ago
-
Location Date
January 03, 2023
2 years ago
-
Status Code
602
-
Current Location
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED
Employee Name
CORNWELL, ANDREA
-
Law Office Assigned Location Code
M60
-
Owners
Mark Drawing Code
4
Mark Identification
XLENTI
Case File Statements
- GS0051: Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; lentiviruses, lentivirus particles and lentivirus plasmids, all for medical and veterinary use
- GS0011: Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; lentiviruses, lentivirus particles and lentivirus plasmids, all for scientific and research purposes
- GS0421: Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of lentiviruses, lentivirus particles and lentivirus plasmids; research, development and bioengineering services relating to lentiviruses; drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services
Case File Event Statements
-
11/25/2021 - 3 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
12/3/2021 - 3 years ago
3 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
6/7/2022 - 2 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/29/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
6/10/2022 - 2 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
6/14/2022 - 2 years ago
7 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
6/14/2022 - 2 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
7/5/2022 - 2 years ago
9 - REFUSAL PROCESSED BY IB
Type: RFNT
-
1/3/2023 - 2 years ago
10 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
1/3/2023 - 2 years ago
11 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Type: MAB2
-
1/3/2023 - 2 years ago
12 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Type: MAB2
-
5/16/2023 - a year ago
15 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Type: OPNX
-
6/9/2022 - 2 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
4/26/2023 - a year ago
13 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Type: OPNR
-
4/26/2023 - a year ago
14 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
1/3/2024 - a year ago
17 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
1/3/2024 - a year ago
16 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
1/22/2024 - 12 months ago
18 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINT
-
11/8/2024 - 2 months ago
19 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP